Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study

Abstract

This open-label observational study showed an improvement, after 2 months of add-on therapy with montelukast, in both asthma and allergic rhinitis symptoms in patients not adequately controlled on a fixed association of ICS/LABA.